Search
Q32 Bio Inc
QTTBAdd to Watchlist
15.140USD
-0.010-0.07%
Close 07-27 16:00（ET）Quotes delayed by 15 min
186.29MMarket Cap
5.43P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Q32 Bio Inc is 8.00, ranking 168 out of 386 in the Biotechnology & Medical Research industry. The average price target is 10.00, with a high of 20.00 and a low of 4.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
38.750
Target Price
+155.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Q32 Bio Inc
QTTB
5
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Q32 Bio Inc's price target?
Analysts forecast that Q32 Bio Inc's price target is USD 10.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 4.00.
How have Q32 Bio IncQTTB's recent earnings per share performed?
The market expectation was USD -0.54, while Q32 Bio IncQTTB's earnings per share (EPS) for the previous quarter was USD 4.59. EPS for the next quarter is expected at USD -0.54.
What is the analyst rating for Q32 Bio Inc?
Based on the ratings of Q32 Bio Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.